Literature DB >> 26169521

An Initial Investigation of Do Not Resuscitate Acceptance in Egypt.

Fetouh S Hassanin1, Mona F Schaalan1, Karim M Kamal1, F DeWolfe Miller2.   

Abstract

BACKGROUND: The aim of this work was to obtain objective data on the extent of knowledge and attitudes of the do not resuscitate (DNR) concept in an Egyptian urban setting.
METHODS: This survey was conducted in Cairo, Egypt, using a structured questionnaire including 23 questions. Questions and questionnaire were developed from literature on DNR in the region and from pilot testing.
RESULTS: A total of 461 persons participated. In all, 48 participants (10.4%, 95% confidence interval [CI]: 7.8-13.7) agreed on the concept of DNR, 226 (49%, 95% CI: 36.1-45.2) stated that it depends on the patient condition, and 187 (40.5%, 95% CI: 44.4-53.7) rejected DNR. Combining the first 2 categories, agree and depends on patient condition, over 60% of the respondents in effect supported DNR. Family members (35.6%, 95% CI: 31.4-40.3) and attending physicians (43.3%, 95% CI: 30.1-39.0) were selected over religious leaders (21%, 95% CI: 17.5-25.2) and representatives from state institutions (4.6%, 95% CI: 2.9-7.0) as to who should have authority for making a DNR decisions. DISCUSSION: These and additional results provide objective evidence that DNR will not be rejected outright in Egypt. More formal surveys are justified and will provide needed guidance for implementing DNR and related end-of-life medical care in Egypt.
© The Author(s) 2015.

Entities:  

Keywords:  Egypt; do not resuscitate; end of life; epidemiology; medical policy; palliative medicine

Mesh:

Year:  2015        PMID: 26169521     DOI: 10.1177/1049909115594613

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  1 in total

1.  Factors affecting the attitudes and opinions of ICU physicians regarding end-of-life decisions for their patients and themselves: A survey study from Turkey.

Authors:  Nur Baykara; Tuğhan Utku; Volkan Alparslan; Mustafa Kemal Arslantaş; Nermin Ersoy
Journal:  PLoS One       Date:  2020-05-20       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.